510(k) Predicate Finder
Find potential predicate devices for your 510(k) submission. Enter a K-number to find all clearances with the same product code, a three-letter product code to browse clearances directly, or search by device name.
Let the assistant find your predicates
Describe your device and the Research Assistant searches 510(k)s, compares intended use, and drafts a predicate shortlist — with citations.
Free to try · every answer cites its records
Cardiac Allograft Gene Expression Profiling Test System
Cardiovascular
The Cardiac Allograft Gene Expression Profiling Test System is an in vitro diagnostic multivariate index assay (IVDMIA) test service performed in a single laboratory that analyzes RNA gene expression profiles from peripheral blood mononuclear cells to aid in identifying heart transplant recipients with stable allograft function who have a low probability of moderate or severe acute cellular rejection at the time of testing, used alongside standard clinical assessment. Classified as FDA Class 2 under regulation 21 CFR 862.1163 within the Cardiovascular medical specialty, it requires a 510(k) premarket notification. The product code is OJQ. It is not flagged as an implant or life-sustaining device.
510(k) Clearances
2 matchesWhat is a Predicate Device?
A predicate device is a legally marketed device that a new 510(k) applicant uses to demonstrate substantial equivalence. The FDA's 510(k) pathway requires manufacturers to show that their device has the same intended use and similar technological characteristics as one or more predicate devices already cleared for commercial distribution.
Finding the right predicate is a critical step in 510(k) strategy. Manufacturers typically search for cleared devices with the same FDA product code, which groups devices by their intended use and regulatory classification. This tool helps you identify potential predicates by browsing all clearances within a product code.
Note that predicate devices must be legally marketed — they cannot be devices that were cleared but never commercialized, or devices subject to a mandatory recall. The determination of substantial equivalence considers intended use, technological characteristics, and performance data.